{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:34:14Z","timestamp":1792056854378,"version":"4.4.0"},"reference-count":127,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010828","name":"Department of Education of Guizhou Province","doi-asserted-by":"publisher","award":["[2023]017"],"award-info":[{"award-number":["[2023]017"]}],"id":[{"id":"10.13039\/501100010828","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004001","name":"Guizhou Provincial Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003459","name":"Guizhou University","doi-asserted-by":"publisher","award":["[2022]004"],"award-info":[{"award-number":["[2022]004"]}],"id":[{"id":"10.13039\/501100003459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.isci.2026.115738","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T20:37:25Z","timestamp":1776285445000},"page":"115738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["From pathogenesis to precision medicine in systemic lupus erythematosus: Emerging biomarkers and targeted interventions"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2700-6423","authenticated-orcid":false,"given":"Weiya","family":"Lan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianwei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wukai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9722-8798","authenticated-orcid":false,"given":"Danyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Rui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.115738_bib1","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/rheumatology\/kex260","article-title":"The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies","volume":"56","author":"Rees","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.isci.2026.115738_bib2","article-title":"Management strategies and future directions for systemic lupus erythematosus in adults","volume":"393","author":"Laura","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.115738_bib3","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.isci.2026.115738_bib4","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.isci.2026.115738_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.11.001","article-title":"Systemic Lupus Erythematosus: Diagnosis and Clinical Management","volume":"96","author":"Fava","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.isci.2026.115738_bib6","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1080\/1744666X.2017.1327352","article-title":"Epidemiology of systemic lupus erythematosus","volume":"13","author":"Pons-Estel","year":"2017","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.isci.2026.115738_bib7","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/ard-2022-223741","article-title":"Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets","volume":"82","author":"Crow","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.isci.2026.115738_bib8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev-immunol-101921-042422","article-title":"Systemic Lupus Erythematosus Pathogenesis: Interferon and Beyond","volume":"41","author":"Caielli","year":"2023","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.115738_bib9","doi-asserted-by":"crossref","first-page":"eabf1970","DOI":"10.1126\/science.abf1970","article-title":"Single-cell RNA-seq reveals cell type-specific molecular and genetic associations to lupus","volume":"376","author":"Perez","year":"2022","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.isci.2026.115738_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.isci.2026.115738_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054514","article-title":"Application of Machine Learning Models in Systemic Lupus Erythematosus","volume":"24","author":"Ceccarelli","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.115738_bib12","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122312","article-title":"Integrated, multicohort analysis reveals unified signature of systemic lupus erythematosus","volume":"5","author":"Haynes","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.isci.2026.115738_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1530327","article-title":"Cellular and molecular determinants mediating the dysregulated germinal center immune dynamics in systemic lupus erythematosus","volume":"16","author":"Georgakis","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.115738_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/BOR.0000000000000862","article-title":"Diagnostic, predictive and prognostic biomarkers in systemic lupus erythematosus: current insights","volume":"34","author":"Lindblom","year":"2022","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.isci.2026.115738_bib15","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/ard-2022-223808","article-title":"Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes","volume":"82","author":"Choi","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.isci.2026.115738_bib16","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.115738_bib17","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1136\/ard-2023-225445","article-title":"Type I interferon blockade with anifrolumab in patients with systemic lupus erythematosus modulates key immunopathological pathways in a gene expression and proteomic analysis of two phase 3 trials","volume":"83","author":"Baker","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.isci.2026.115738_bib18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/stcltm\/szae044","article-title":"Current cell therapies for systemic lupus erythematosus","volume":"13","author":"Dao","year":"2024","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.isci.2026.115738_bib19","doi-asserted-by":"crossref","first-page":"7694","DOI":"10.1182\/blood-2024-206122","article-title":"Evaluating the Effectiveness and Tolerability of Chimeric Antigen Receptor (CAR) T Cells Therapy in Patient with Systemic Lupus Erythematosus: A Systematic Review","volume":"144","author":"Devi","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.115738_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-024-01105-8","article-title":"Bispecific CAR-T cells targeting CD19\/20 in patients with relapsed or refractory B cell non-Hodgkin lymphoma: a phase I\/II trial","volume":"14","author":"Wang","year":"2024","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.isci.2026.115738_bib21","article-title":"Association of IL-37 levels and genetic variants with systemic lupus erythematosus: a meta-analysis","volume":"15","author":"Lee","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.115738_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147619","article-title":"Biomarkers Associated with Organ-Specific Involvement in Juvenile Systemic Lupus Erythematosus","volume":"22","author":"Greenan-Barrett","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.115738_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102463","article-title":"A review and meta-analysis of anti-ribosomal P autoantibodies in systemic lupus erythematosus","volume":"19","author":"Choi","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.isci.2026.115738_bib24","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.autrev.2018.02.011","article-title":"The 2018 pipeline of targeted therapies under clinical development for Systemic Lupus Erythematosus: a systematic review of trials","volume":"17","author":"Felten","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.isci.2026.115738_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102873","article-title":"B cell-targeted therapies in systemic lupus erythematosus","volume":"132","author":"Arbitman","year":"2022","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.isci.2026.115738_bib26","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/08820139.2025.2475816","article-title":"Immunomodulatory Role and Therapeutic Potential of HLA-DR+ Regulatory T Cells in Systemic Lupus Erythematosus","volume":"54","author":"Zhang","year":"2025","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.isci.2026.115738_bib27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41590-020-0677-6","article-title":"Autoimmunity and organ damage in systemic lupus erythematosus","volume":"21","author":"Tsokos","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2026.115738_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-36306-5","article-title":"Multi-ancestry and multi-trait genome-wide association meta-analyses inform clinical risk prediction for systemic lupus erythematosus","volume":"14","author":"Khunsriraksakul","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115738_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1710571","article-title":"The origin of autoimmune diseases: is there a role for ancestral HLA-II haplotypes in immune hyperactivity","volume":"16","author":"Ruiz-Pablos","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.115738_bib30","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/annrheumdis-2017-212794","article-title":"The STAT4 SLE risk allele rs7574865[T] is associated with increased IL-12-induced IFN-\u03b3 production in T cells from patients with SLE","volume":"77","author":"Hagberg","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.isci.2026.115738_bib31","first-page":"4533","article-title":"Recent Advances of Type I Interferon on the Regulation of Immune Cells and the Treatment of Systemic Lupus Erythematosus","volume":"18","author":"Wang","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.isci.2026.115738_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103722","article-title":"A20 haploinsufficiency diagnosis beyond systemic lupus erythematosus: A systematic review of the literature","volume":"24","author":"Philip","year":"2025","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.isci.2026.115738_bib33","doi-asserted-by":"crossref","first-page":"26506","DOI":"10.1074\/jbc.M110.111104","article-title":"Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue","volume":"285","author":"Fiorillo","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.115738_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/genes12050680","article-title":"Epigenetic Contribution and Genomic Imprinting Dlk1-Dio3 miRNAs in Systemic Lupus Erythematosus","volume":"12","author":"Dai","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.isci.2026.115738_bib35","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41576-024-00796-w","article-title":"Genomic landscape of cancer in racially and ethnically diverse populations","volume":"26","author":"Thomas","year":"2025","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.isci.2026.115738_bib36","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00439-024-02716-8","article-title":"Advancements and limitations in polygenic risk score methods for genomic prediction: a scoping review","volume":"143","author":"Jayasinghe","year":"2024","journal-title":"Hum. Genet."},{"key":"10.1016\/j.isci.2026.115738_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01697","article-title":"Systemic Lupus Erythematosus and DNA Degradation and Elimination Defects","volume":"10","author":"Arneth","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.115738_bib38","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/09612033221148099","article-title":"DNA methylation alterations in systemic lupus erythematosus: A systematic review of case-control studies","volume":"32","author":"Ehtesham","year":"2023","journal-title":"Lupus"},{"key":"10.1016\/j.isci.2026.115738_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/genes13061016","article-title":"Discovery and Functional Characterization of Two Regulatory Variants Underlying Lupus Susceptibility at 2p13.1","volume":"13","author":"Fazel-Najafabadi","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.isci.2026.115738_bib40","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13148-015-0152-7","article-title":"Genome-wide DNA methylation profiling of CD8+ T cells shows a distinct epigenetic signature to CD4+ T cells in multiple sclerosis patients","volume":"7","author":"Maltby","year":"2015","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.isci.2026.115738_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-17930-1","article-title":"Epigenomic profiling of immune cell subtypes reveals H3K27ac-marked stress signatures after long-duration spaceflight","volume":"15","author":"Fullstone","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.115738_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.799788","article-title":"Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus: Novel Insights into Mechanisms and Promising Therapeutic Strategies","volume":"12","author":"Pan","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.115738_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000776","article-title":"Gut microbiota in SLE: from animal models to clinical evidence and pharmacological perspectives","volume":"10","author":"Toumi","year":"2023","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.isci.2026.115738_bib44","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-025-04318-1","article-title":"Unravelling the connection between interferons and systemic lupus erythematosus: a systematic review and meta-analysis","volume":"23","author":"Khatri","year":"2025","journal-title":"BMC Med."},{"key":"10.1016\/j.isci.2026.115738_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001180","article-title":"Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus","volume":"3","author":"Lande","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2026.115738_bib46","article-title":"Neutrophil extracellular traps in autoimmune diseases: Analysis of the knowledge map","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.115738_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102592","article-title":"The immunologic etiology of psychiatric manifestations in systemic lupus erythematosus: A narrative review on the role of the blood brain barrier, antibodies, cytokines and chemokines","volume":"19","author":"Deijns","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.isci.2026.115738_bib47","doi-asserted-by":"crossref","first-page":"R87","DOI":"10.1186\/ar3014","article-title":"Inhibitor of IkappaB kinase activity, BAY 11-7082, interferes with interferon regulatory factor 7 nuclear translocation and type I interferon production by plasmacytoid dendritic cells","volume":"12","author":"Miyamoto","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.isci.2026.115738_bib48","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1056\/NEJMoa2118025","article-title":"Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus","volume":"387","author":"Furie","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.115738_bib49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12519-019-00229-3","article-title":"Immunological pathogenesis and treatment of systemic lupus erythematosus","volume":"16","author":"Pan","year":"2019","journal-title":"World Journal of Pediatrics"},{"key":"10.1016\/j.isci.2026.115738_bib50","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.17152","article-title":"Incidence and risk factors of systemic lupus erythematosus in patients with primary immune thrombocytopenia: a systematic review and meta-analysis","volume":"12","author":"Zhou","year":"2024","journal-title":"PeerJ"},{"key":"10.1016\/j.isci.2026.115738_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107910","article-title":"Immune mitochondrial complex I mediates vascular damage in toll-like receptor 7 (TLR7)-induced lupus","volume":"220","author":"Mi\u00f1ano","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.isci.2026.115738_bib53","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.jaci.2018.10.041","article-title":"Loss of an IgG plasma cell checkpoint in patients with lupus","volume":"143","author":"Suurmond","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.isci.2026.115738_bib54","article-title":"Imbalance of Th17 cells, Treg cells and associated cytokines in patients with systemic lupus erythematosus: a meta-analysis","volume":"15","author":"Huang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.115738_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103648","article-title":"Immunopathogenesis of systemic lupus erythematosus: An update","volume":"23","author":"Arnaud","year":"2024","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.isci.2026.115738_bib56","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev-cellbio-100617-062518","article-title":"Non-Antibody-Secreting Functions of B Cells and Their Contribution to Autoimmune Disease","volume":"35","author":"Getahun","year":"2019","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.isci.2026.115738_bib57","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.isci.2026.115738_bib58","doi-asserted-by":"crossref","DOI":"10.1093\/jalm\/jfab146","article-title":"Anti-dsDNA Testing Specificity for Systemic Lupus Erythematosus: A Systematic Review","volume":"7","author":"Orme","year":"2022","journal-title":"The journal of applied laboratory medicine"},{"key":"10.1016\/j.isci.2026.115738_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002517","article-title":"Dissecting signalling pathways associated with intrarenal synthesis of complement components in lupus nephritis","volume":"8","author":"Tampe","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.isci.2026.115738_bib60","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41584-020-0480-7","article-title":"New insights into the role of antinuclear antibodies in systemic lupus erythematosus","volume":"16","author":"Pisetsky","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.isci.2026.115738_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1279","article-title":"Autoantibodies against complement component C1q in systemic lupus erythematosus","volume":"10","author":"Trendelenburg","year":"2021","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.isci.2026.115738_bib62","doi-asserted-by":"crossref","DOI":"10.1007\/s12519-019-00229-3","article-title":"Immunological pathogenesis and treatment of systemic lupus erythematosus","volume":"16","author":"Pan","year":"2020","journal-title":"World Journal of Pediatrics"},{"key":"10.1016\/j.isci.2026.115738_bib51","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/CM9.0000000000003406","article-title":"CAR-based cell therapies for systemic lupus erythematosus","volume":"138","author":"Wang","year":"2025","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.isci.2026.115738_bib63","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41584-025-01321-x","article-title":"Insights into the pathogenesis of childhood-onset SLE in the past decade","volume":"22","author":"Robinson","year":"2026","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.isci.2026.115738_bib127","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1590\/2175-8239-jbn-2018-0097","article-title":"Pediatric lupus nephritis","volume":"41","author":"Pinheiro","year":"2019","journal-title":"J. Bras. Nefrol."},{"key":"10.1016\/j.isci.2026.115738_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13102472","article-title":"Interferons in Autoimmunity: From Loss of Tolerance to Chronic Inflammation","volume":"13","author":"Mihaescu","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.isci.2026.115738_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11195759","article-title":"Current Insights on Biomarkers in Lupus Nephritis: A Systematic Review of the Literature","volume":"11","author":"Palazzo","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.isci.2026.115738_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111327","article-title":"Cytokines as Biomarkers in Systemic Lupus Erythematosus: Value for Diagnosis and Drug Therapy","volume":"22","author":"Idborg","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.115738_bib67","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000542","article-title":"Achieving remission or low disease activity is associated with better outcomes in patients with systemic lupus erythematosus: a systematic literature review","volume":"8","author":"Ugarte-Gil","year":"2021","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.isci.2026.115738_bib69","article-title":"The Role of JAK Inhibitors in the Treatment of Cutaneous Lupus Erythematosus: A Review","volume":"23","author":"Dinkins","year":"2024","journal-title":"J. Drugs Dermatol. JDD : J. Drugs Dermatol. JDD"},{"key":"10.1016\/j.isci.2026.115738_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00344","article-title":"Selective Janus Kinase 1 Inhibition Is a Promising Therapeutic Approach for Lupus Erythematosus Skin Lesions","volume":"11","author":"Fetter","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.115738_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1410032","article-title":"Anti-C1q antibodies: a biomarker for diagnosis and management of lupus nephritis. A narrative review","volume":"15","author":"Calatroni","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.115738_bib72","article-title":"Cellular Aspects of the Pathogenesis of Lupus Nephritis","volume":"33","author":"Anthony","year":"2021","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.isci.2026.115738_bib73","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12016-021-08865-2","article-title":"Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus (NPSLE): Can They Be Used as Biomarkers for the Differential Diagnosis of This Disease?","volume":"63","author":"Manca","year":"2022","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.isci.2026.115738_bib74","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2015.10.003","article-title":"A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus","volume":"15","author":"Ho","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.isci.2026.115738_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics15070824","article-title":"High-Resolution Vessel Wall Images and Neuropsychiatric Lupus: A Scoping Review","volume":"15","author":"Matos","year":"2025","journal-title":"Diagnostics"},{"key":"10.1016\/j.isci.2026.115738_bib76","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/BOR.0000000000000308","article-title":"Cutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus","volume":"28","author":"Stannard","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.isci.2026.115738_bib77","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/BOR.0000000000000739","article-title":"Cutaneous and systemic connections in lupus","volume":"32","author":"Maz","year":"2020","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.isci.2026.115738_bib78","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/MOP.0000000000000383","article-title":"Immunogenetics of Cutaneous Lupus Erythematosus","volume":"28","author":"Hersh","year":"2016","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.isci.2026.115738_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11102814","article-title":"Update of Potential Biomarkers in Risk Prediction and Monitoring of Atherosclerosis in Systemic Lupus Erythematosus to Prevent Cardiovascular Disease","volume":"11","author":"Blachut","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.isci.2026.115738_bib80","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.autrev.2015.10.002","article-title":"Subclinical atherosclerosis in patients with systemic lupus erythematosus: A systemic review and meta-analysis","volume":"15","author":"Wu","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.isci.2026.115738_bib81","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.semarthrit.2017.03.022","article-title":"Joint involvement in systemic lupus erythematosus: From pathogenesis to clinical assessment","volume":"47","author":"Ceccarelli","year":"2017","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.isci.2026.115738_bib82","article-title":"Advances in the management of systemic lupus erythematosus","volume":"383","author":"Morand","year":"2023","journal-title":"BMJ (Pract. Obs. Ed.)"},{"key":"10.1016\/j.isci.2026.115738_bib83","first-page":"1958","article-title":"Elevated integrin \u03b1v\u03b23 expression activates the NF-\u03baB p65\/p100 pathway and promotes inflammatory responses in systemic lupus erythematosus","volume":"43","author":"Song","year":"2025","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.isci.2026.115738_bib84","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-018-1649-1","article-title":"The plasma biomarker soluble SIGLEC-1 is associated with the type I interferon transcriptional signature, ethnic background and renal disease in systemic lupus erythematosus","volume":"20","author":"Oliveira","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.isci.2026.115738_bib85","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2021-221662","article-title":"Anti-RNP antibodies are associated with the interferon gene signature but not decreased complement levels in SLE","volume":"81","author":"Hubbard","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.isci.2026.115738_bib86","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.ard.2025.04.006","article-title":"Enhanced B cell and complement cascade gene signatures in patients with neuropsychiatric systemic lupus erythematosus","volume":"84","author":"Nikolopoulos","year":"2025","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.isci.2026.115738_bib87","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.138345","article-title":"Integrated urine proteomics and renal single-cell genomics identify an IFN-\u03b3 response gradient in lupus nephritis","volume":"5","author":"Fava","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.isci.2026.115738_bib88","article-title":"Integrative analysis of COL6A3 in lupus nephritis: insights from single-cell transcriptomics and proteomics","volume":"15","author":"Mou","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.115738_bib89","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.2147\/IJGM.S522871","article-title":"Single Cell and Transcriptomic Analysis of Regulatory Mechanisms of Key Genes in Systemic Lupus Erythematosus","volume":"18","author":"Zhou","year":"2025","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.isci.2026.115738_bib90","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-020-02177-0","article-title":"The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysis","volume":"22","author":"Wilkinson","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.isci.2026.115738_bib91","doi-asserted-by":"crossref","DOI":"10.1097\/BOR.0000000000000922","article-title":"An update on autoantibodies in systemic lupus erythematosus","volume":"35","author":"G\u00f3mez-Ba\u00f1uelos","year":"2023","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.isci.2026.115738_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103897","article-title":"Neutrophil extracellular traps and neuropsychiatric lupus: Signaling pathways involved in NET formation and mechanisms affecting the central nervous system","volume":"24","author":"Guan","year":"2025","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.isci.2026.115738_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.792884","article-title":"Frontiers | LncRNA Expression Profiles in Systemic Lupus Erythematosus and Rheumatoid Arthritis: Emerging Biomarkers and Therapeutic Targets","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.115738_bib94","article-title":"Frontiers | Unlocking the secrets of NPSLE: the role of dendritic cell-secreted CCL2 in blood-brain barrier disruption","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.115738_bib95","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.19536","article-title":"The potential mechanism of Huangqin for treatment of systemic lupus erythematosus based on network pharmacology, molecular docking and molecular dynamics simulation","volume":"13","author":"Zheng","year":"2025","journal-title":"PeerJ"},{"key":"10.1016\/j.isci.2026.115738_bib96","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2147\/ITT.S485650","article-title":"Immunotargets and Therapy for Systemic Lupus Erythematosus","volume":"14","author":"Mok","year":"2025","journal-title":"ImmunoTargets Ther."},{"key":"10.1016\/j.isci.2026.115738_bib97","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211073001","article-title":"Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge","volume":"14","author":"Dima","year":"2022","journal-title":"Therapeutic advances in Musculoskeletal Disease"},{"key":"10.1016\/j.isci.2026.115738_bib98","doi-asserted-by":"crossref","DOI":"10.1136\/ard-2023-225319","article-title":"Management of systemic lupus erythematosus: a systematic literature review informing the 2023 update of the EULAR recommendations","volume":"83","author":"Kostopoulou","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.isci.2026.115738_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26030929","article-title":"Advances in Targeted Therapy for Systemic Lupus Erythematosus: Current Treatments and Novel Approaches","volume":"26","author":"Saegusa","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.115738_bib100","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/14712598.2021.1895744","article-title":"Belimumab: a step forward in the treatment of systemic lupus erythematosus","volume":"21","author":"Depascale","year":"2021","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.isci.2026.115738_bib101","doi-asserted-by":"crossref","DOI":"10.1177\/09612033221090888","article-title":"Efficacy and safety of belimumab therapy in systemic lupus erythematosus: A systematic review and meta-analysis","volume":"31","author":"Chiang","year":"2022","journal-title":"Lupus"},{"key":"10.1016\/j.isci.2026.115738_bib102","article-title":"A focused report on IFN-1 targeted therapies for lupus erythematosus","volume":"34","author":"Bhatt","year":"2025","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.isci.2026.115738_bib103","doi-asserted-by":"crossref","DOI":"10.1080\/14728222.2020.1832464","article-title":"Systemic lupus erythematosus (SLE): emerging therapeutic targets","volume":"24","author":"Mathias","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.isci.2026.115738_bib104","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1007\/s12325-022-02281-4","article-title":"A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19","volume":"39","author":"Bieber","year":"2022","journal-title":"Adv. Ther."},{"key":"10.1016\/j.isci.2026.115738_bib105","article-title":"Progress in the Pathogenesis and Treatment of Neuropsychiatric Systemic Lupus Erythematosus","volume":"11","author":"Wang","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.isci.2026.115738_bib106","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1182\/blood-2023-186669","article-title":"CD19\/BCMA CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus - Safety and Preliminary Efficacy Data from a Phase I Clinical Study","volume":"142","author":"Feng","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.115738_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2024.102482","article-title":"The path ahead for understanding Toll-like receptor-driven systemic autoimmunity","volume":"91","author":"Hamerman","year":"2024","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.isci.2026.115738_bib108","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adi9769","article-title":"UNC93B1 variants underlie TLR7-dependent autoimmunity","volume":"9","author":"Wolf","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.isci.2026.115738_bib109","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s12291-023-01179-4","article-title":"SHR0302 Improves Treg\/Th17 Imbalance in Patients with Systemic Lupus Erythematosus","volume":"40","author":"Mohammad","year":"2025","journal-title":"Indian J. Clin. Biochem."},{"key":"10.1016\/j.isci.2026.115738_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1617451","article-title":"Frontiers | Enhancing the treatment potential of IL-17 antagonism in lupus nephritis: finding the right partner","volume":"16","author":"Gao","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.115738_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103025","article-title":"Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus","volume":"136","author":"Lindblom","year":"2023","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.isci.2026.115738_bib112","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000424","article-title":"Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways","volume":"7","author":"D\u00f6rner","year":"2020","journal-title":"Lupus Science & Medicine"},{"key":"10.1016\/j.isci.2026.115738_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2025.101471","article-title":"Impact of a digital platform and flare risk blood biomarker index on lupus: A study protocol design for evaluating self efficacy and disease management","volume":"45","author":"Jupe","year":"2025","journal-title":"Contemporary Clinical Trials Communications"},{"key":"10.1016\/j.isci.2026.115738_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.978851","article-title":"MX2: Identification and systematic mechanistic analysis of a novel immune-related biomarker for systemic lupus erythematosus","volume":"13","author":"Meng","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.115738_bib115","article-title":"Identification of hub immune-related genes and construction of predictive models for systemic lupus erythematosus by bioinformatics combined with machine learning","volume":"12","author":"Zhang","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.isci.2026.115738_bib116","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-10853-1","article-title":"Interpretable machine learning identifies paediatric Systemic Lupus Erythematosus subtypes based on gene expression data","volume":"12","author":"Yones","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.115738_bib117","article-title":"A deep learning model for predicting systemic lupus erythematosus-associated epitopes","volume":"25","author":"Jiale","year":"2025","journal-title":"BMC Med. Inf. Decis. Making"},{"key":"10.1016\/j.isci.2026.115738_bib118","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000303","article-title":"10 most important contemporary challenges in the management of SLE","volume":"6","author":"Felten","year":"2019","journal-title":"Lupus Sci. Med."},{"key":"10.1016\/j.isci.2026.115738_bib119","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-025-01113-3","article-title":"Management of childhood-onset systemic lupus erythematosus (cSLE) over the last two decades in Spain","volume":"23","author":"Boteanu","year":"2025","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"10.1016\/j.isci.2026.115738_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102887","article-title":"Systemic lupus erythematosus-complicating immune thrombocytopenia: From pathogenesis to treatment","volume":"132","author":"Jiang","year":"2022","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.isci.2026.115738_bib121","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-025-03584-x","article-title":"Prospective analysis of B cell subset dynamics following telitacicept treatment in systemic lupus erythematosus","volume":"27","author":"Chen","year":"2025","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.isci.2026.115738_bib122","first-page":"39","article-title":"Towards Precision Medicine in Systemic Lupus Erythematosus","volume":"13","author":"Lever","year":"2020","journal-title":"Pharmgenomics. Pers. Med."},{"key":"10.1016\/j.isci.2026.115738_bib123","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/ng.3434","article-title":"Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus","volume":"47","author":"Bentham","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2026.115738_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103675","article-title":"The mosaic of systemic lupus erythematosus: From autoimmunity to autoinflammation and immunodeficiency and back","volume":"23","author":"Lamas","year":"2024","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.isci.2026.115738_bib125","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41590-024-01898-7","article-title":"The immunology of systemic lupus erythematosus","volume":"25","author":"Tsokos","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2026.115738_bib126","article-title":"CAR T-cell therapy in autoimmune diseases: a promising frontier on the horizon","volume":"16","author":"Wu","year":"2025","journal-title":"Front. Immunol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226011132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226011132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T16:15:55Z","timestamp":1783181755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226011132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":127,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2589004226011132"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.115738","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From pathogenesis to precision medicine in systemic lupus erythematosus: Emerging biomarkers and targeted interventions","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.115738","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115738"}}